Beyfortus 50 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FBGMZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $54,207
Award facts
- Contract value 100% obligated
- $54,207.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $54,207.01 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Beyfortus 50 mg/0.5 mL syringes. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of September 23, 2025. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Beyfortus is a respiratory syncytial virus (RSV) monoclonal antibody used for passive immunization, making this contract part of DLA's critical role in ensuring adequate vaccine and immunobiological product availability for military personnel and beneficiaries. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability as a major pharmaceutical distributor serving military and veteran healthcare systems, with consistent delivery of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains through competitive procurement processes.
Quick answers
Who was awarded contract SPE2DB25FBGMZ?
SPE2DB25FBGMZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FBGMZ worth?
The government has obligated $54,207 on SPE2DB25FBGMZ.
Is contract SPE2DB25FBGMZ an order under another contract?
Yes. SPE2DB25FBGMZ is a delivery order under SPE2DB24D2100, an indefinite delivery contract.
Was contract SPE2DB25FBGMZ competed?
The extent of competition for SPE2DB25FBGMZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award